Latest News & Features
Americas
The US Patent and Trademark Office has rejected a request by biopharmaceutical company Celgene to sanction hedge fund manager Kyle Bass and his organisation the Coalition for Affordable Drugs. 28 September 2015
Americas
Concern surrounding how the Unified Patent Court will operate echoes the worry that US patent owners had ahead of the Patent Trial and Appeal Board’s implementation, a US law firm has observed. 28 September 2015
Big Pharma
A counsel for pharmaceutical company Novartis has said he “embraces” the Unified Patent Court, but has concerns about securing preliminary injunctions and the harmonisation of supplementary protection certificates under the agreement. 28 September 2015
Americas
A US appeals court has upheld a lower court ruling that patents owned by Shire covering an ADHD treatment drug are valid, but reversed a separate judgment that said pharmaceutical company Johnson Matthey induced infringement. 25 September 2015
Asia
An Indian court has granted pharmaceutical company Micro Labs permission to sue a rival, despite there being questions surrounding whether the suit should be heard at the court. 24 September 2015
Big Pharma
An advocate-general at Europe’s highest court has said SPCs should come into effect once an applicant for a marketing authorisation has been notified of that authorisation. This is good news for SPC owners, say Anja Lunze and Paul England of Taylor Wessing. 24 September 2015
Americas
US biotechnology company BioMarin Pharmaceutical has agreed to settle its patent infringement lawsuit against Dr Reddy’s Laboratories centring on its Kuvan (sapropterin dihydrochloride) drug. 23 September 2015
Africa
More than 150 tonnes of counterfeit medicine have been seized in southern Africa. 22 September 2015
Americas
Acorda Therapeutics has sued rival Par Pharmaceutical accusing it of infringing patents related to multiple sclerosis treatment drug Ampyra. 21 September 2015
Americas
Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid. 18 September 2015